In Brief: FDA gender differences workshop
FDA gender differences workshop: FDA Office of Women's Health and the drugs, biologics and devices centers will sponsor a public workshop Nov. 6 and 7 on scientific issues related to gender analysis in product applications. FDA is convening the workshop to respond to questions raised by FDA reviewers industry, and other groups about the agency's "Guideline for the Study and Evaluation of Gender Differences in the Clinical Evaluation of Drugs" issued in July 1993...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth